25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Lepu Biopharma Co Ltd
Buy, Hold or Sell?

Let's analyze Lepu Biopharma Co Ltd together

I guess you are interested in Lepu Biopharma Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Lepu Biopharma Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Lepu Biopharma Co Ltd

I send you an email if I find something interesting about Lepu Biopharma Co Ltd.

1. Quick Overview

1.1. Quick analysis of Lepu Biopharma Co Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Lepu Biopharma Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
HK$0.58
Expected worth in 1 year
HK$0.54
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
HK$-0.03
Return On Investment
-1.1%

For what price can you sell your share?

Current Price per Share
HK$2.87
Expected price per share
HK$2.16 - HK$2.94
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Lepu Biopharma Co Ltd (5 min.)




Live pricePrice per Share (EOD)
HK$2.87
Intrinsic Value Per Share
HK$0.67 - HK$0.96
Total Value Per Share
HK$1.25 - HK$1.54

2.2. Growth of Lepu Biopharma Co Ltd (5 min.)




Is Lepu Biopharma Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$122.7m$124.3m-$1.6m-1.4%

How much money is Lepu Biopharma Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$2.8m-$88.5m$85.7m3,018.4%
Net Profit Margin-9.8%-4,424.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Lepu Biopharma Co Ltd (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Lepu Biopharma Co Ltd?

Welcome investor! Lepu Biopharma Co Ltd's management wants to use your money to grow the business. In return you get a share of Lepu Biopharma Co Ltd.

First you should know what it really means to hold a share of Lepu Biopharma Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Lepu Biopharma Co Ltd is HK$2.87. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Lepu Biopharma Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Lepu Biopharma Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$0.58. Based on the TTM, the Book Value Change Per Share is HK$-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is HK$0.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Lepu Biopharma Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps0.00-0.1%0.00-0.1%-0.05-1.9%-0.04-1.5%-0.04-1.5%
Usd Book Value Change Per Share0.000.0%0.000.0%0.010.2%0.010.5%0.010.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.000.0%0.010.2%0.010.5%0.010.5%
Usd Price Per Share0.54-0.54-0.94-0.30-0.30-
Price to Earnings Ratio-316.18--316.18--17.70--66.78--66.78-
Price-to-Total Gains Ratio-539.04--539.04-155.30--191.87--191.87-
Price to Book Ratio7.32-7.32-12.60-3.98-3.98-
Price-to-Total Gains Ratio-539.04--539.04-155.30--191.87--191.87-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.368795
Number of shares2711
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.01
Usd Total Gains Per Share0.000.01
Gains per Quarter (2711 shares)-2.7240.09
Gains per Year (2711 shares)-10.88160.37
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-11-210160150
20-22-320321310
30-33-430481470
40-44-540641630
50-54-650802790
60-65-760962950
70-76-87011231110
80-87-98012831270
90-98-109014431430
100-109-120016041590

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.05.00.00.0%0.05.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%2.03.00.040.0%2.03.00.040.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.05.00.0%0.00.05.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%2.03.00.040.0%2.03.00.040.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Lepu Biopharma Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.008-0.0080%0.047-117%0.115-107%0.115-107%
Book Value Per Share--0.5750.5750%0.583-1%0.483+19%0.483+19%
Current Ratio--0.7530.7530%0.963-22%0.935-20%0.935-20%
Debt To Asset Ratio--0.6270.6270%0.644-3%0.698-10%0.698-10%
Debt To Equity Ratio--1.6681.6680%1.808-8%1.122+49%1.122+49%
Dividend Per Share----0%-0%-0%-0%
Eps---0.013-0.0130%-0.415+3018%-0.329+2370%-0.329+2370%
Free Cash Flow Per Share---0.189-0.1890%-0.383+103%-0.385+104%-0.385+104%
Free Cash Flow To Equity Per Share---0.189-0.1890%0.285-166%0.074-357%0.074-357%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.962--------
Intrinsic Value_10Y_min--0.672--------
Intrinsic Value_1Y_max---0.269--------
Intrinsic Value_1Y_min---0.262--------
Intrinsic Value_3Y_max---0.530--------
Intrinsic Value_3Y_min---0.506--------
Intrinsic Value_5Y_max---0.455--------
Intrinsic Value_5Y_min---0.441--------
Market Cap4753724362.240-47%6986262767.9806986262767.9800%12196919574.000-43%3836636468.396+82%3836636468.396+82%
Net Profit Margin---0.098-0.0980%-44.249+45029%-8.869+8946%-8.869+8946%
Operating Margin----0%-41.2060%-8.2410%-8.2410%
Operating Ratio--2.8312.8310%42.359-93%9.038-69%9.038-69%
Pb Ratio4.988-47%7.3167.3160%12.602-42%3.984+84%3.984+84%
Pe Ratio-215.542+32%-316.178-316.1780%-17.701-94%-66.776-79%-66.776-79%
Price Per Share2.870-47%4.2104.2100%7.350-43%2.312+82%2.312+82%
Price To Free Cash Flow Ratio-15.178+32%-22.264-22.2640%-19.195-14%-8.292-63%-8.292-63%
Price To Total Gains Ratio-367.468+32%-539.038-539.0380%155.302-447%-191.868-64%-191.868-64%
Quick Ratio--0.1130.1130%0.935-88%0.942-88%0.942-88%
Return On Assets---0.009-0.0090%-0.254+2840%-0.242+2707%-0.242+2707%
Return On Equity---0.023-0.0230%-0.712+3005%-0.445+1843%-0.445+1843%
Total Gains Per Share---0.008-0.0080%0.047-117%0.115-107%0.115-107%
Usd Book Value--122705697.275122705697.2750%124371136.817-1%103477257.490+19%103477257.490+19%
Usd Book Value Change Per Share---0.001-0.0010%0.006-117%0.015-107%0.015-107%
Usd Book Value Per Share--0.0740.0740%0.075-1%0.062+19%0.062+19%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.002-0.0020%-0.053+3018%-0.042+2370%-0.042+2370%
Usd Free Cash Flow---40322221.564-40322221.5640%-81653620.512+103%-82720098.295+105%-82720098.295+105%
Usd Free Cash Flow Per Share---0.024-0.0240%-0.049+103%-0.049+104%-0.049+104%
Usd Free Cash Flow To Equity Per Share---0.024-0.0240%0.037-166%0.009-357%0.009-357%
Usd Market Cap610853580.548-47%897734765.685897734765.6850%1567304165.259-43%493007786.189+82%493007786.189+82%
Usd Price Per Share0.369-47%0.5410.5410%0.944-43%0.297+82%0.297+82%
Usd Profit---2839336.000-2839336.0000%-88543182.000+3018%-70701445.300+2390%-70701445.300+2390%
Usd Revenue--28957732.00028957732.0000%2001002.000+1347%6191746.800+368%6191746.800+368%
Usd Total Gains Per Share---0.001-0.0010%0.006-117%0.015-107%0.015-107%
 EOD+3 -5MRQTTM+0 -0YOY+17 -155Y+20 -1210Y+20 -12

3.3 Fundamental Score

Let's check the fundamental score of Lepu Biopharma Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-215.542
Price to Book Ratio (EOD)Between0-14.988
Net Profit Margin (MRQ)Greater than0-0.098
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.113
Current Ratio (MRQ)Greater than10.753
Debt to Asset Ratio (MRQ)Less than10.627
Debt to Equity Ratio (MRQ)Less than11.668
Return on Equity (MRQ)Greater than0.15-0.023
Return on Assets (MRQ)Greater than0.05-0.009
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Lepu Biopharma Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.137
Ma 20Greater thanMa 503.097
Ma 50Greater thanMa 1003.214
Ma 100Greater thanMa 2003.054
OpenGreater thanClose2.880
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Lepu Biopharma Co Ltd

Lepu Biopharma Co., Ltd., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for cancer targeted therapy and immunotherapy in China and internationally. The company offers PUYOUHENG (Pucotenlimab Injection), a humanized IgG4 mAb against human PD-1 for the treatment of solid tumors and melanoma. It is also developing MRG003 that is in phase III clinical study for treating nasopharyngeal cancer, and head and neck squamous cell carcinoma; and MRG002, which is in phase III trials to treat breast and urothelial cancer, as well as HER2-positive. In addition, the company is developing MRG001 CD20-targeted ADC for treating non-Hodgkin's lymphoma; CMG901 CLDN18.2-targeted ADC for treating gastric and gastroesophageal junction carcinoma and other solid tumors; and MRG004A TF-targeted ADC for treating advanced or metastatic solid tumors. Further, it is developing CG00705 Oncolytic virus for treating bacillus calmette-guerin unresponsive non-muscle invasive bladder cancer; and MRG006A and CTM012 for the treatment of solid tumors. The company was incorporated in 2018 and is headquartered in Shanghai, China.

Fundamental data was last updated by Penke on 2024-11-22 16:29:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Lepu Biopharma Co Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Lepu Biopharma Co Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -9.8% means that $-0.10 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Lepu Biopharma Co Ltd:

  • The MRQ is -9.8%. The company is making a loss. -1
  • The TTM is -9.8%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-9.8%TTM-9.8%0.0%
TTM-9.8%YOY-4,424.9%+4,415.1%
TTM-9.8%5Y-886.9%+877.1%
5Y-886.9%10Y-886.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.8%-115.9%+106.1%
TTM-9.8%-210.8%+201.0%
YOY-4,424.9%-214.5%-4,210.4%
5Y-886.9%-342.2%-544.7%
10Y-886.9%-464.5%-422.4%
4.3.1.2. Return on Assets

Shows how efficient Lepu Biopharma Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Lepu Biopharma Co Ltd to the Biotechnology industry mean.
  • -0.9% Return on Assets means that Lepu Biopharma Co Ltd generated $-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Lepu Biopharma Co Ltd:

  • The MRQ is -0.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.9%TTM-0.9%0.0%
TTM-0.9%YOY-25.4%+24.5%
TTM-0.9%5Y-24.2%+23.3%
5Y-24.2%10Y-24.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.9%-11.1%+10.2%
TTM-0.9%-11.7%+10.8%
YOY-25.4%-11.3%-14.1%
5Y-24.2%-12.7%-11.5%
10Y-24.2%-14.3%-9.9%
4.3.1.3. Return on Equity

Shows how efficient Lepu Biopharma Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Lepu Biopharma Co Ltd to the Biotechnology industry mean.
  • -2.3% Return on Equity means Lepu Biopharma Co Ltd generated $-0.02 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Lepu Biopharma Co Ltd:

  • The MRQ is -2.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -2.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.3%TTM-2.3%0.0%
TTM-2.3%YOY-71.2%+68.9%
TTM-2.3%5Y-44.5%+42.2%
5Y-44.5%10Y-44.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.3%-14.2%+11.9%
TTM-2.3%-15.8%+13.5%
YOY-71.2%-13.9%-57.3%
5Y-44.5%-18.5%-26.0%
10Y-44.5%-19.5%-25.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Lepu Biopharma Co Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Lepu Biopharma Co Ltd is operating .

  • Measures how much profit Lepu Biopharma Co Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Lepu Biopharma Co Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Lepu Biopharma Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-4,120.6%+4,120.6%
TTM-5Y-824.1%+824.1%
5Y-824.1%10Y-824.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--258.6%+258.6%
TTM--318.3%+318.3%
YOY-4,120.6%-224.0%-3,896.6%
5Y-824.1%-386.5%-437.6%
10Y-824.1%-497.6%-326.5%
4.3.2.2. Operating Ratio

Measures how efficient Lepu Biopharma Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 2.83 means that the operating costs are $2.83 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Lepu Biopharma Co Ltd:

  • The MRQ is 2.831. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.831. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.831TTM2.8310.000
TTM2.831YOY42.359-39.528
TTM2.8315Y9.038-6.207
5Y9.03810Y9.0380.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8312.594+0.237
TTM2.8313.360-0.529
YOY42.3593.299+39.060
5Y9.0384.788+4.250
10Y9.0386.528+2.510
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Lepu Biopharma Co Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Lepu Biopharma Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.75 means the company has $0.75 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Lepu Biopharma Co Ltd:

  • The MRQ is 0.753. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.753. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.753TTM0.7530.000
TTM0.753YOY0.963-0.211
TTM0.7535Y0.935-0.183
5Y0.93510Y0.9350.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7533.658-2.905
TTM0.7533.874-3.121
YOY0.9634.672-3.709
5Y0.9355.960-5.025
10Y0.9356.277-5.342
4.4.3.2. Quick Ratio

Measures if Lepu Biopharma Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Lepu Biopharma Co Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 0.11 means the company can pay off $0.11 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Lepu Biopharma Co Ltd:

  • The MRQ is 0.113. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.113. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.113TTM0.1130.000
TTM0.113YOY0.935-0.822
TTM0.1135Y0.942-0.829
5Y0.94210Y0.9420.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1133.104-2.991
TTM0.1133.426-3.313
YOY0.9354.498-3.563
5Y0.9425.933-4.991
10Y0.9426.426-5.484
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Lepu Biopharma Co Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Lepu Biopharma Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Lepu Biopharma Co Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.63 means that Lepu Biopharma Co Ltd assets are financed with 62.7% credit (debt) and the remaining percentage (100% - 62.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Lepu Biopharma Co Ltd:

  • The MRQ is 0.627. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.627. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.627TTM0.6270.000
TTM0.627YOY0.644-0.017
TTM0.6275Y0.698-0.071
5Y0.69810Y0.6980.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6270.354+0.273
TTM0.6270.345+0.282
YOY0.6440.311+0.333
5Y0.6980.366+0.332
10Y0.6980.382+0.316
4.5.4.2. Debt to Equity Ratio

Measures if Lepu Biopharma Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Lepu Biopharma Co Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 166.8% means that company has $1.67 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Lepu Biopharma Co Ltd:

  • The MRQ is 1.668. The company is just able to pay all its debts with equity.
  • The TTM is 1.668. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.668TTM1.6680.000
TTM1.668YOY1.808-0.140
TTM1.6685Y1.122+0.546
5Y1.12210Y1.1220.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6680.398+1.270
TTM1.6680.437+1.231
YOY1.8080.378+1.430
5Y1.1220.452+0.670
10Y1.1220.495+0.627
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Lepu Biopharma Co Ltd generates.

  • Above 15 is considered overpriced but always compare Lepu Biopharma Co Ltd to the Biotechnology industry mean.
  • A PE ratio of -316.18 means the investor is paying $-316.18 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Lepu Biopharma Co Ltd:

  • The EOD is -215.542. Based on the earnings, the company is expensive. -2
  • The MRQ is -316.178. Based on the earnings, the company is expensive. -2
  • The TTM is -316.178. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-215.542MRQ-316.178+100.636
MRQ-316.178TTM-316.1780.000
TTM-316.178YOY-17.701-298.477
TTM-316.1785Y-66.776-249.402
5Y-66.77610Y-66.7760.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-215.542-2.160-213.382
MRQ-316.178-2.428-313.750
TTM-316.178-3.145-313.033
YOY-17.701-3.304-14.397
5Y-66.776-6.080-60.696
10Y-66.776-6.625-60.151
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Lepu Biopharma Co Ltd:

  • The EOD is -15.178. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -22.264. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -22.264. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-15.178MRQ-22.264+7.086
MRQ-22.264TTM-22.2640.000
TTM-22.264YOY-19.195-3.069
TTM-22.2645Y-8.292-13.972
5Y-8.29210Y-8.2920.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-15.178-2.980-12.198
MRQ-22.264-3.295-18.969
TTM-22.264-3.682-18.582
YOY-19.195-4.523-14.672
5Y-8.292-8.162-0.130
10Y-8.292-9.239+0.947
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Lepu Biopharma Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 7.32 means the investor is paying $7.32 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Lepu Biopharma Co Ltd:

  • The EOD is 4.988. Based on the equity, the company is fair priced.
  • The MRQ is 7.316. Based on the equity, the company is overpriced. -1
  • The TTM is 7.316. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD4.988MRQ7.316-2.329
MRQ7.316TTM7.3160.000
TTM7.316YOY12.602-5.286
TTM7.3165Y3.984+3.333
5Y3.98410Y3.9840.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.9881.869+3.119
MRQ7.3162.027+5.289
TTM7.3162.365+4.951
YOY12.6022.419+10.183
5Y3.9843.668+0.316
10Y3.9844.362-0.378
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,384,306
Total Liabilities1,495,606
Total Stockholder Equity896,905
 As reported
Total Liabilities 1,495,606
Total Stockholder Equity+ 896,905
Total Assets = 2,384,306

Assets

Total Assets2,384,306
Total Current Assets677,146
Long-term Assets1,707,160
Total Current Assets
Cash And Cash Equivalents 426,015
Short-term Investments 63,628
Net Receivables 37,802
Inventory 29,412
Total Current Assets  (as reported)677,146
Total Current Assets  (calculated)556,857
+/- 120,289
Long-term Assets
Property Plant Equipment 1,017,351
Goodwill 52,636
Intangible Assets 480,556
Long-term Assets  (as reported)1,707,160
Long-term Assets  (calculated)1,550,543
+/- 156,617

Liabilities & Shareholders' Equity

Total Current Liabilities899,561
Long-term Liabilities596,045
Total Stockholder Equity896,905
Total Current Liabilities
Short Long Term Debt 434,299
Accounts payable 207,611
Total Current Liabilities  (as reported)899,561
Total Current Liabilities  (calculated)641,910
+/- 257,651
Long-term Liabilities
Long term Debt 260,000
Capital Lease Obligations Min Short Term Debt52,523
Long-term Liabilities  (as reported)596,045
Long-term Liabilities  (calculated)312,523
+/- 283,522
Total Stockholder Equity
Total Stockholder Equity (as reported)896,905
Total Stockholder Equity (calculated)0
+/- 896,905
Other
Capital Stock1,659,445
Common Stock Shares Outstanding 1,659,445
Net Debt 268,284
Net Invested Capital 1,591,204
Net Working Capital -222,415
Property Plant and Equipment Gross 1,229,385



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-31
> Total Assets 
1,525,281
2,423,611
2,082,061
2,529,172
2,384,306
2,384,3062,529,1722,082,0612,423,6111,525,281
   > Total Current Assets 
221,539
843,349
314,132
812,801
677,146
677,146812,801314,132843,349221,539
       Cash And Cash Equivalents 
188,545
402,867
155,168
669,397
426,015
426,015669,397155,168402,867188,545
       Short-term Investments 
0
350,657
50,000
0
63,628
63,628050,000350,6570
       Net Receivables 
-452
117
84,780
119,343
37,802
37,802119,34384,780117-452
       Inventory 
8,082
19,569
24,184
24,061
29,412
29,41224,06124,18419,5698,082
       Other Current Assets 
7,189
7,690
9,045
8,747
0
08,7479,0457,6907,189
   > Long-term Assets 
1,303,742
1,580,262
1,767,929
1,716,371
1,707,160
1,707,1601,716,3711,767,9291,580,2621,303,742
       Property Plant Equipment 
491,292
716,065
948,140
1,002,761
1,017,351
1,017,3511,002,761948,140716,065491,292
       Goodwill 
52,636
52,636
52,636
52,636
52,636
52,63652,63652,63652,63652,636
       Intangible Assets 
464,697
497,922
422,454
398,177
480,556
480,556398,177422,454497,922464,697
       Other Assets 
154,700
152,009
176,431
104,095
0
0104,095176,431152,009154,700
> Total Liabilities 
1,877,781
950,100
1,245,347
1,628,410
1,495,606
1,495,6061,628,4101,245,347950,1001,877,781
   > Total Current Liabilities 
1,215,636
382,221
549,057
843,786
899,561
899,561843,786549,057382,2211,215,636
       Short Long Term Debt 
380,620
0
60,409
359,988
434,299
434,299359,98860,4090380,620
       Accounts payable 
31,684
42,448
158,818
166,129
207,611
207,611166,129158,81842,44831,684
       Other Current Liabilities 
365,624
296,847
311,043
287,242
0
0287,242311,043296,847365,624
   > Long-term Liabilities 
495,285
539,668
685,921
784,624
596,045
596,045784,624685,921539,668495,285
       Long term Debt Total 
166,517
180,800
251,947
293,150
0
0293,150251,947180,800166,517
       Long term Debt 
118,266
147,266
232,469
290,057
260,000
260,000290,057232,469147,266118,266
       Capital Lease Obligations Min Short Term Debt
75,816
52,000
38,265
40,259
52,523
52,52340,25938,26552,00075,816
       Other Liabilities 
49,687
49,687
49,687
49,687
0
049,68749,68749,68749,687
       Long-term Liabilities Other 
12,000
12,000
12,000
0
0
0012,00012,00012,000
> Total Stockholder Equity
-352,500
1,473,511
836,714
900,762
896,905
896,905900,762836,7141,473,511-352,500
   Retained Earnings -2,353,586-2,331,490-1,642,438-631,442-542,415
   Accumulated Other Comprehensive Income 00000
   Capital Surplus 
0
0
1,841,680
2,419,845
0
02,419,8451,841,68000
   Treasury Stock00000



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in HKD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue225,352
Cost of Revenue-28,277
Gross Profit197,075197,075
 
Operating Income (+$)
Gross Profit197,075
Operating Expense-609,681
Operating Income-384,329-412,606
 
Operating Expense (+$)
Research Development458,073
Selling General Administrative129,953
Selling And Marketing Expenses-
Operating Expense609,681588,026
 
Net Interest Income (+$)
Interest Income8,049
Interest Expense-14,677
Other Finance Cost-1,340
Net Interest Income-7,968
 
Pretax Income (+$)
Operating Income-384,329
Net Interest Income-7,968
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-30,301-384,329
EBIT - interestExpense = -14,677
-22,096
-7,419
Interest Expense14,677
Earnings Before Interest and Taxes (EBIT)--15,624
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-30,301
Tax Provision-0
Net Income From Continuing Ops-30,301-30,301
Net Income-22,096
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-7,968
 

Technical Analysis of Lepu Biopharma Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Lepu Biopharma Co Ltd. The general trend of Lepu Biopharma Co Ltd is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Lepu Biopharma Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Lepu Biopharma Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 2.91 < 2.94 < 2.94.

The bearish price targets are: 2.16.

Tweet this
Lepu Biopharma Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Lepu Biopharma Co Ltd. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Lepu Biopharma Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Lepu Biopharma Co Ltd. The current macd is -0.06867209.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Lepu Biopharma Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Lepu Biopharma Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Lepu Biopharma Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Lepu Biopharma Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartLepu Biopharma Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Lepu Biopharma Co Ltd. The current adx is 10.69.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Lepu Biopharma Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Lepu Biopharma Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Lepu Biopharma Co Ltd. The current sar is 3.58485978.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Lepu Biopharma Co Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Lepu Biopharma Co Ltd. The current rsi is 42.14. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Lepu Biopharma Co Ltd Daily Relative Strength Index (RSI) ChartLepu Biopharma Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Lepu Biopharma Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Lepu Biopharma Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Lepu Biopharma Co Ltd Daily Stochastic Oscillator ChartLepu Biopharma Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Lepu Biopharma Co Ltd. The current cci is -101.25494241.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Lepu Biopharma Co Ltd Daily Commodity Channel Index (CCI) ChartLepu Biopharma Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Lepu Biopharma Co Ltd. The current cmo is -22.21481984.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Lepu Biopharma Co Ltd Daily Chande Momentum Oscillator (CMO) ChartLepu Biopharma Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Lepu Biopharma Co Ltd. The current willr is -90.32258065.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Lepu Biopharma Co Ltd Daily Williams %R ChartLepu Biopharma Co Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Lepu Biopharma Co Ltd.

Lepu Biopharma Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Lepu Biopharma Co Ltd. The current atr is 0.2357945.

Lepu Biopharma Co Ltd Daily Average True Range (ATR) ChartLepu Biopharma Co Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Lepu Biopharma Co Ltd. The current obv is 13,305,431.

Lepu Biopharma Co Ltd Daily On-Balance Volume (OBV) ChartLepu Biopharma Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Lepu Biopharma Co Ltd. The current mfi is 55.66.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Lepu Biopharma Co Ltd Daily Money Flow Index (MFI) ChartLepu Biopharma Co Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Lepu Biopharma Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-10MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-01MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-08-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-11MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-07BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-09ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Lepu Biopharma Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Lepu Biopharma Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.137
Ma 20Greater thanMa 503.097
Ma 50Greater thanMa 1003.214
Ma 100Greater thanMa 2003.054
OpenGreater thanClose2.880
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Lepu Biopharma Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Lepu Biopharma Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Lepu Biopharma Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Lepu Biopharma Co Ltd

I send you an email if I find something interesting about Lepu Biopharma Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Lepu Biopharma Co Ltd.

Receive notifications about Lepu Biopharma Co Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.